In series I 152 fetuses were monitored but tpH did not change the management of labour. In series II 96 fetuses were monitored with CTG and tpH as follows:
CTG normal: no intervention irrespective of the tpH value, because of possible false low tpH measurements. CTG pathological (late decelerations, severe variable decelerations, severe bradycardia, decreased variability + tachycardia) and tpH more than 7.20 (7.15 if delivery could be expected within 15 minutes): no intervention. CTG pathological and tpH less than 7.20 (7.15): operative delivery should be performed. Seventy-two successful monitorings (75 per cent) in series II were matched to 72 monitorings in series I according to age and parity. A decreased number of outlet forceps/vacuum extractions was found if tpH was used in the management of labour (26 versus 9 per cent). The state of neonates did not differ (Apgar scores one and five minutes after delivery, umbilical artery and vein pH, pC02,base excess, standard bicarbonate, pU2 , oxygen saturation, hemoglobin).
Although theoretically there are situations in which tpH differs from blood pH, we have found a good correlation between tpH and blood pH (r= 0.78 and 0.67 (n=81) when comparing tpH to umbilical artery and vein, respectively).
The disadvantages of tpH monitoring with the present electrode are: 1) it is difficult to use -and even after a long training period the success rate is only about 75 per cent. 2) The electrode is too big and the tip of the electrode is too close to the skin incision.
3) The price of the electrode is now more than 500 £. Consequently, we need a smaller and cheaper electrode which is easy to handle and with electrode characteristics as accurate as the Roche electrode. If this can be accomplished the results with the Roche electrode indicates that such an electrode will be a valuable instrument in the handling of high risk deliveries and deliveries in which the CTG ( or the transcutaneous COa/Oz ) is not completely normal. 
